|
|
 |
|
Viewing report
|
|
|
|
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
Business Insights, April 2005, Pages: 186
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, is a new report which provides an in-depth analysis of three technological innovations that are being heralded to revolutionize the drug discovery process by rapidly expediting drug discovery research. This report focuses on lab-on-a-chip (LOC) devices, nanotechnology and RNA interference drug discovery technologies that are increasingly being used to identify novel drug targets and to successfully reduce R&D timelines.
This report also provides:
- In-depth analysis of the market forces
- Current and future technological advances
- Detailed company profiles
- Eight year forecasts of market size for LOC devices, nanotechnology in drug discovery and RNA interference technologies and therapeutics
Incorporate the most innovative technologies into your drug discovery process, significantly reduce R&D timelines and build a unique competitive edge with the help of this latest report.
Key Findings of the Report:
- The markets for LOC devices, nanotechnology, and RNAi technologies and therapeutics are set to experience phenomenal growth rates, driven
by novel product developments and new market entrants.
- The nanotechnology market is forecast to reach $955m by 2012, a CAGR (2004-2012) of 28.3%, while the LOC/microfluidics market is projected to generate sales of $1,530m in 2012, a CAGR of 35.5%. The larger RNAi market is predicted to be worth $1.1bn in 2012, although its CAGR is lower at 16.1%.
- Some of the major factors driving growth and expansion of the LOC device market include: high throughput screening, increased automation, reduction in sample requirement, reduced exposure to hazardous materials, and the increased rate at which potential drug targets are screened.
- At an embryonic stage of development, nano-enabled drugs are already bringing clinical benefits to thousands of patients. Two examples are Abraxane for the treatment of metastatic breast cancer, and RenaZorb, which provides phosphate control in kidney dialysis patients
- The resolution of several patent and licensing disputes, which threatened to halt the growth and expansion of the RNAi field, is now allowing more companies to enter the RNAi field. This is expected to further boost RNAi market growth in the future.
Key questions answered in this report
- What will the market for lab-on-a-chip (LOC), nanoenabled drug discovery and RNAi technology be worth in 2012?
- How can these three technologies be effectively applied in the drug discovery process?
- What are the major factors driving and restraining market expansion of these technologies in drug discovery?
- Who are the leading players within each of the three markets and how competitive or fragmented are the markets?
- Which pharmaceutical and biotech companies are investing in lab-on-a-chip (LOC), nanotechnology and RNAi, and what strategic alliances, partnerships and agreements have been formed during the last few years?
Top five reasons to buy this copy today:
1.) Gain insight into new technological developments in LOC devices, nanotechnology and RNAi and their applications in the pharmaceutical industry to develop new drugs.
2.) Improve productivity and reduce R&D expenditure by understanding how LOC devices, nanotechnology and RNAi technology can be
applied to all stages of the drug development process.
3.) Review in-depth analysis of strategic alliances, acquisitions and agreements between pharmaceutical/biotech companies and LOC,
nanotechnology and RNAi vendors.
4.) Understand where LOC devices, nanotechnology and RNAi have already impacted the identification of new drug targets and biomarkers for diagnosis screening.
5.) Highlight the efficacy and potential long-term cost effectiveness of LOC devices, nanotechnology and RNAi for drug discovery.
Customers who bought this item also bought
The Impact of Nanotechnology in Drug Discovery: Global Developments, Market Analysis and Future Prospects
Nanotechnology: Worldwide IC Market
Nanotechnology: Impact Of Nanoelectronics On The U.S. Electronics Industry
RNAi - Technologies, Markets and Companies
Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery
Nanotechnology Market Opportunities, Strategies, and Forecasts, 2004 to 2009
The Nanotechnology Opportunity Report Vol 1 & 2 2nd Edition
Fluorescent Proteins: Technologies, Applications, and Opportunities for Drug Discovery
|
|
|
|
